These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25765358)

  • 1. Early serum human chorionic gonadotropin (hCG) trends after medication abortion.
    Pocius KD; Maurer R; Fortin J; Goldberg AB; Bartz D
    Contraception; 2015 Jun; 91(6):503-6. PubMed ID: 25765358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
    Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB
    Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring medical abortion using mifepristone/misoprostol combination with ultrasonogram and serum human chorionic gonadotropin.
    Chou SY; Chen CY; Chiang HK; Chow PK; Wang CC; Hsu CS
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):48-52. PubMed ID: 17272208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol.
    Creinin MD
    Am J Obstet Gynecol; 1996 Feb; 174(2):776-8. PubMed ID: 8623820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trend of serum beta-human chorionic gonadotropin levels after medical abortion in the early first trimester of pregnancy.
    Choobun T; Maneeon R
    J Obstet Gynaecol Res; 2023 Jan; 49(1):103-108. PubMed ID: 36184565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hCG trends after mifepristone and misoprostol for undesired pregnancy of unknown location.
    Bharadwa S; Fulcher I; Fortin J; Pocius KD; Goldberg AB
    Contraception; 2024 Mar; 131():110343. PubMed ID: 38008304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hCG threshold to assess medical abortion success.
    Le Lous M; Gallinand AC; Laviolle B; Peltier L; Nyangoh Timoh K; Lavoué V
    Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):458-463. PubMed ID: 30601107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Goldberg AB; Fulcher IR; Fortin J; Hofer RK; Cottrill A; Dethier D; Gilbert A; Janiak E; Roncari D
    Obstet Gynecol; 2022 May; 139(5):771-780. PubMed ID: 35576336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovulation resumption after medical abortion with mifepristone and misoprostol.
    Schreiber CA; Sober S; Ratcliffe S; Creinin MD
    Contraception; 2011 Sep; 84(3):230-3. PubMed ID: 21843685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy.
    Honkanen H; Ranta S; Ylikorkala O; Heikinheimo O
    Hum Reprod; 2002 Sep; 17(9):2315-9. PubMed ID: 12202418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
    Blum J; Sheldon WR; Ngoc NT; Winikoff B; Nga NT; Martin R; Van Thanh L; Blumenthal PD
    Contraception; 2016 Aug; 94(2):115-21. PubMed ID: 27067706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical abortion with mifepristone and misoprostol: a clinical trial in Taiwanese women.
    Tsai EM; Yang CH; Lee JN
    J Formos Med Assoc; 2002 Apr; 101(4):277-82. PubMed ID: 12101864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness.
    Parashar P; Iversen OE; Midbøe G; Myking O; Bjørge L
    Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):366-71. PubMed ID: 17853164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of terminating biochemical pregnancy and early clinical pregnancy with mifepristone and misoprostol].
    Li CL; Wei M; Fu MF; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):542-5. PubMed ID: 17983494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
    Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of medical abortion for clinical practice.
    Bryant AG; Regan E; Stuart G
    Obstet Gynecol Surv; 2014 Jan; 69(1):39-45. PubMed ID: 25102250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum human chorionic gonadotropin decline following aspiration abortion in early pregnancy less than 42 days gestation.
    Baldwin MK; Bednarek PH; Russo J
    Contraception; 2021 Feb; 103(2):113-115. PubMed ID: 33227249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
    Roe AH; Abernathy A; Flynn AN; McAllister A; Koelper NC; Sammel MD; Schreiber CA; Sonalkar S
    Obstet Gynecol; 2022 Jun; 139(6):1149-1151. PubMed ID: 35675613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined methotrexate and misoprostol for early induced abortion.
    Schaff EA; Eisinger SH; Franks P; Kim SS
    Arch Fam Med; 1995 Sep; 4(9):774-9. PubMed ID: 7647943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early pregnancy termination with mifepristone and misoprostol in the United States.
    Spitz IM; Bardin CW; Benton L; Robbins A
    N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.